Oramax 0.5gm/0.5gm Injection
By Oramax
Rx
1 Powder for Injection in a Vial

Composition
Cefoperazone(0.5gm) + Sulbactam(0.5gm)

Manufacturer - Alpha Aromatic Pvt Ltd
Banglow No. 6, Kariappa Road, Canntt. Varanasi-221002.

Expires on or after
September, 2025

liver
Limited information is accessible regarding the administration of Oramax 0.5gm/0.5gm Injection in individuals with liver disease. It is advised to seek guidance from your doctor before using this medication to ensure its safety and effectiveness for individuals with liver conditions.

kidney
Consult your doctor regarding the use of Oramax 0.5gm/0.5gm Injection in patients with kidney disease, as limited information is available on its safety in such cases.

alcohol
It is advised to avoid consuming alcohol while taking Oramax 0.5gm/0.5gm Injection as it may lead to symptoms like flushing, increased heart rate, nausea, chest pain, and low blood pressure (Disulfiram reaction).

driving
It is uncertain if Oramax 0.5gm/0.5gm Injection affects driving ability. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Oramax 0.5gm/0.5gm Injection is generally considered safe during pregnancy. Animal studies show minimal harm to the baby, yet human studies are limited.

breastfeeding
Oramax 0.5gm/0.5gm Injection is considered safe during breastfeeding. Research shows that the medication does not transfer significantly into breastmilk, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹150
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024